Non-alcoholic fatty liver disease (NAFLD) is the major public health challenge for
hepatologists in the twenty-first century. NAFLD comprises a histological spectrum ranging …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the
most common underlying causes of chronic liver injury. They are associated with a wide …

Significance: Nonalcoholic fatty liver disease (NAFLD), characterized by liver triacylglycerol
build-up, has been growing in the global world in concert with the raised prevalence of …

Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of liver injury ranging
from simple steatosis to steatohepatitis, fibrosis, and cirrhosis. Whereas simple steatosis has …

The worldwide rising prevalence of obesity and insulin resistance is associated with a
parallel increase in nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by …

Non-alcoholic fatty liver disease (NAFLD) has an increasing prevalence in Western society.
Unfortunately, the pathogenesis of NAFLD, from hepatic lipid overload, steatosis to non …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized pathology with a
high prevalence and a possible evolution to its inflammatory counterpart (non-alcoholic …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common liver disease in the
world. It encompasses a histological spectrum, ranging from simple, nonprogressive …

Nonalcoholic fatty liver disease (NAFLD) is a pathology that contains a broad liver
dysfunctions spectrum. These alterations span from noninflammatory isolated steatosis until …

Nonalcoholic fatty liver disease (NAFLD) represents a broad spectrum of histological
abnormalities with clinical presentations ranging from hepatic steatosis to nonalcoholic …